Your browser doesn't support javascript.
Markers of Coagulation Dysfunction and Inflammation in Diabetic and Non Diabetic COVID-19 Patients- A Retrospective Study
Journal of Clinical and Diagnostic Research ; 16(6):BC12-BC16, 2022.
Article in English | EMBASE | ID: covidwho-1918104
ABSTRACT
group and non diabetic control group. Data was presented as

Introduction:

Since the end of 2019, a novel Coronavirus percentages for categorical variables and median (interquartile Disease 2019 (COVID-19), declared a pandemic by World Health range) for continuous variables. Chi-square test was used to see Organization (WHO) has ravaged the world. Diabetic patients the association of different qualitative information and Mann-have been reported to be more susceptible to intensive care Whitney U test was used to see the association of quantitative admissions, and deaths due to COVID-19. Diabetes Mellitus data and all p-values were given for justification. A p-value <0.05 (DM) and COVID-19, both associated with chronic and acute was considered statistically significant. inflammation respectively can impact each other in terms of

Results:

The sample included 300 diabetic and 200 non diabetic clinical progression and outcome. Given the novelty of Severe COVID-19 patients. The mean age non diabetic patients (47.5 Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) years) was significantly less as compared to the diabetic group pathogen, there is need to update and increase the limited (54.5 years), p-value <0.001. The serum level of inflammatory evidence on the probability of DM acting as a risk factor and biomarkers, C-Reactive Protein (CRP), ferritin, and markers of influencing disease severity and progression. hypercoagulable state, D-dimer, was found to be significantly high

Aim:

To compare the markers of inflammation and coagulation (p-value <0.001) in diabetic patients as compared to non diabetic dysfunction between COVID-19 patients with and without DM patients. Diabetics had a poor prognosis with 231 (77%) receiving as co-morbidity and thereby to study the effect DM has on the oxygen as compared to 51 (25.5%) of non diabetic patients. Total prognosis of COVID-19. 173 (57.7%) of diabetic COVID-19 patients had to be shifted to Materials and

Methods:

This was a retrospective, observational, ICU, 201 (67%) suffered from post COVID-19 complications and single-centre study, conducted Department of Biochemistry at the mortality rate was higher at 18% in diabetics as compared to Gauhati Medical College and Hospital, Guwahati, Assam, India, 1.5% in non diabetic subjects. from January 2021 to June 2021. Clinical and laboratory data

Conclusion:

Diabetic patients are at higher risk of uncontrolled of 500 laboratory confirmed COVID-19 patients were reviewed inflammation and hypercoagulable state which eventually leads in this study. The patients were grouped as diabetic case to deterioration of COVID-19 infection status.
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Observational study Language: English Journal: Journal of Clinical and Diagnostic Research Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Observational study Language: English Journal: Journal of Clinical and Diagnostic Research Year: 2022 Document Type: Article